Studies a combined cholesterol pill in adults with high cholesterol
Observes a pitavastatin and ezetimibe combination pill in adults with high cholesterol.
Plain-language title generated from the registry record
Registry title: A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
Key facts
- Where
- Seoul, South KoreaSee the site
Where in South Korea
- Ewha Womans University Seoul HospitalSeoul, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Boryung Pharmaceutical Co., Ltd
- Trial code
- NCT06314919
- Record updated
- 12 September 2025
- Original description
The purpose of this study is to evaluate the efficacy and safety of fixed-Dose combination of Pitavastatin/Ezetimibe under the real-world conditionRead full original descriptionShow less
A Multicenter, Prospective, Cohort Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimibe Under the Real-World Condition
The purpose of this study is to evaluate the efficacy and safety of fixed-Dose combination of Pitavastatin/Ezetimibe under the real-world condition
Inclusion: Those who taking statins or statins and ezetimibe in addition to dietary and exercise therapy for primary hypercholesterolemia or mixed hyperlipidemia; Those who are judged to need administration of a fixed-dose combination of pitavastatin/ezetimibe for change of statin's formulation or change of statin's dose, addition of ezetimibe.
Exclusion: Those who have been administered an investigational product within 12 weeks of the enrollment date or are planning to participate in another clinical trial during this study participation period; Those with hypersensitivity reactions or relevant medical history to pitavastatin or ezetimibe; Those who are taking a fixed-dose combination of pitavastatin/ezetimibe at study enrollment.